 |
Articles: Cardiac/Hypertension |
Prior Articles
Ins and outs of cardiac voltage-gated potassium channels
Current Opinion in Pharmacology, 06/18/09
TGF-beta and BMPR-II pharmacology-implications for pulmonary vascular diseases
Current Opinion in Pharmacology, 06/18/09 Mechanisms of hypoxic pulmonary vasoconstriction and their roles in pulmonary hypertension: new findings for an old problem
Current Opinion in Pharmacology, 06/17/09 Outcomes of Perioperative beta-Blockade in Patients Undergoing Noncardiac Surgery: A Meta-Analysis
Annals of Pharmacotherapy, 06/17/09 The role of fixed-dose combinations in the management of hypertension: focus on lercanidipine-enalapril
Expert Opinion in Pharmacotherapy, 06/17/09 Cost-effectiveness of Intensive Lipid Lowering Therapy with 80mg of Atorvastatin, Versus 10mg of Atorvastatin, for Secondary Prevention of Cardiovascular Disease in Canada
Canadian Journal of Clinical Pharmacology, 06/17/09 Differential Effects of Antihypertensive Treatment on the Retinal Microcirculation. An Anglo-Scandinavian Cardiac Outcomes Trial Substudy
Hypertension, 06/17/09 Folic acid fortification may prevent severe congenital heart defects
American Pharmacists Association, 06/16/09
Free full text
Serotonin and pulmonary hypertension—from bench to bedside
Current Opinion in Pharmacology, 06/16/09 Narrative Review: Statin-Related Myopathy
Annals of Internal Medicine, 06/16/09
Revew Article
Diuretics: still essential drugs for the management of hypertension
Expert Review of Cardiovascular Therapy, 06/16/09 Clopidogrel Adherence Following Percutaneous Coronary Intervention with a Drug-Eluting Stent in a VA Medical Center
Journal of Pharmacy Technology, 06/16/09 New investigational combination telmisartan and amlodipine shows effective and well-tolerated 24-hour blood pressure control in hypertensive patients at risk of cardiovascular events
Boehringer Ingelheim, 06/15/09
Free full text
A randomized, comparative study evaluating the efficacy and tolerability of losartan-low dose chlorthalidone (6.25 mg) combination with losartan-hydrochlorothiazide (12.5 mg) combination in Indian patients with mild-to-moderate essential hypertension
Expert Opinion in Pharmacotherapy, 06/12/09
Exclusive Author Commentary Heart Failure and Adverse Drug Reactions Among Hospitalized Older Adults
Clinical Pharmacology & Therapeutics, 06/11/09 Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases
Journal of Pharmacology and Experimental Therapeutics, 06/10/09 Telmisartan did not prevent recurrent stroke or major cardiovascular events
Evidence-Based Medicine, 06/10/09 Aspirin plus extended-release dipyridamole and clopidogrel were similarly effective for preventing recurrent stroke
Evidence-Based Medicine, 06/10/09 Review: less than maximum doses of ACE inhibitors lower BP to near maximum levels in hypertension
Evidence-Based Medicine, 06/10/09 Rosuvastatin prevented major cardiovascular events in people with elevated C-reactive protein
Evidence-Based Medicine, 06/10/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
